Related Experiment Videos
Activation of the integrated stress response regulates lovastatin-induced apoptosis
Nima Niknejad1, Melissa Morley, Jim Dimitroulakos
1Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ontario K1H 8L6, Canada.
Abstract:
Lovastatin, a potent inhibitor of mevalonate synthesis, can readily induce apoptosis in a subset of human tumor types including head and neck squamous cell carcinomas (HNSCC). We recently identified activation of transcription factor (ATF) 4 as a lovastatin induced gene in HNSCC cells. ATF4 plays a significant role in regulating cellular responses to a wide variety of stress inducers known as the integrated stress response (ISR). These cell stresses lead to the phosphorylation of eukaryotic initiation factor (eIF) 2alpha shutting down global protein translation. However, the translation of ATF4 is enhanced. In this study, lovastatin treatment induced eIF2alpha phosphorylation and inhibited global protein translation. ATF4 expression was induced followed by increased ATF3 and CHOP expression, targets of ATF4 activity, in SCC25 HNSCC cells. In CHOP(-/-) murine embryonic fibroblasts (MEFs), lovastatin-induced apoptosis was attenuated indicating a role for CHOP in this response. Furthermore, the eIF2alpha kinase GCN2 mediates lovastatin induction of ATF4 and lovastatin-induced apoptosis was also attenuated in GCN2(-/-) MEFs. The pro-drug version of lovastatin has potential proteasome inhibitory activity and recently a variety of well established proteasome inhibitors were shown to activate the ISR. In this study, neither the pro-drug nor the active forms of lovastatin had any significant effect on proteasome activity. Therefore, lovastatin, by targeting mevalonate synthesis, is a potent inducer of the ISR through a novel and as yet unrecognized mechanism.
Insights
Lovastatin induces apoptosis in head and neck cancer by activating the integrated stress response (ISR) pathway. This involves the transcription factor ATF4 and its downstream targets, independent of proteasome activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Stress Response
Background:
- Lovastatin inhibits mevalonate synthesis and induces apoptosis in certain human tumors, including head and neck squamous cell carcinomas (HNSCC).
- Activation of transcription factor 4 (ATF4) was identified as a lovastatin-induced gene in HNSCC cells.
- ATF4 is a key regulator of the integrated stress response (ISR), a cellular mechanism responding to various stress inducers.
Purpose of the Study:
- To investigate the mechanism by which lovastatin induces apoptosis in HNSCC cells.
- To determine the role of the integrated stress response (ISR) pathway, specifically ATF4 and its downstream targets, in lovastatin-induced apoptosis.
- To explore the involvement of eukaryotic initiation factor 2alpha (eIF2alpha) kinase GCN2 and C/EBP homologous protein (CHOP) in this process.
Main Methods:
- Treatment of SCC25 HNSCC cells and CHOP(-/-) and GCN2(-/-) murine embryonic fibroblasts (MEFs) with lovastatin.
- Analysis of eIF2alpha phosphorylation, global protein translation, and expression of ATF4, ATF3, and CHOP.
- Assessment of lovastatin's effect on proteasome activity.
- Evaluation of apoptosis induction in response to lovastatin treatment in wild-type and knockout MEFs.
Main Results:
- Lovastatin treatment induced eIF2alpha phosphorylation and inhibited global protein translation in SCC25 cells.
- ATF4 expression was induced by lovastatin, followed by increased expression of its targets ATF3 and CHOP.
- Lovastatin-induced apoptosis was attenuated in CHOP(-/-) and GCN2(-/-) MEFs, indicating a crucial role for CHOP and GCN2.
- Lovastatin did not significantly affect proteasome activity, ruling out this mechanism for ISR activation.
Conclusions:
- Lovastatin induces apoptosis in HNSCC cells through a novel mechanism involving the activation of the ISR.
- The GCN2-eIF2alpha-ATF4 pathway, leading to CHOP expression, is critical for lovastatin-induced apoptosis.
- Lovastatin acts as a potent inducer of the ISR by targeting mevalonate synthesis, independent of proteasome inhibition.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway
Apoptosis